ABSTRACT Eight patients with a posteroseptal accessory pathway and symptomatic atrial fibrillation and/or orthodromic reciprocating tachycardia underwent attempted transcatheter ablation of the accessory pathway. A quadripolar electrode catheter was positioned within the coronary sinus such that the proximal pair of electrodes straddled the os. This proximal pair of electrodes was made electrically common and connected to the cathodal output of a defibrillator. A patch electrode placed over the midthoracic spine was connected to the anodal sink of the defibrillator. Two to three transcatheter shocks were delivered, with a cumulative energy of 600 to 900 J. Immediately after the shocks were delivered, retrograde accessory pathway conduction was absent in each patient. Anterograde conduction through the posteroseptal accessory pathway was absent in six patients and could not be assessed in two patients who each had a second right-sided accessory pathway. Long-term results were assessed in seven patients 4 to 11 months after delivery of the shocks. Anterograde and retrograde conduction through the posteroseptal accessory pathway was absent in five patients. In one patient, retrograde accessory pathway conduction was absent and anterograde conduction was present but was slower than at baseline. In this patient, orthodromic tachycardia was no longer inducible and the ventricular rate during induced atrial fibrillation was 150 beats/min, compared with 220 beats/min before the attempted ablation. He has remained asymptomatic without antiarrhythmic drug therapy for 18 months. In one patient, the transcatheter shocks had no long-term effect on accessory pathway conduction. The shocks delivered at the os of the coronary sinus were well tolerated. There was no long-term effect on anterograde conduction through the atrioventricular junction. Retrograde conduction through the atrioventricular junction was impaired in three patients. In four patients who underwent direct or angiographic visualization of the coronary sinus, no abnormalities were seen. Transcatheter ablation of posteroseptal accessory pathways has a long-term success rate of at least 75% and a low morbidity rate. Closed-chest catheter ablation of posteroseptal accessory pathways is an attractive alternative to surgical ablation of these pathways. Circulation 72, No. 1, 170-177, 1985. EXPERIENCE in more than 150 patients with supraventricular tachycardia refractory to pharmacologic treatment has indicated that catheter ablation of the atrioventricular junction results in good or excellent arrhythmia control in approximately 90% of patients. 1,2 Catheter ablation of accessory pathways has also been attempted, but with less overall success. Attempts at ablation of left-sided accessory pathways by shocks delivered within the coronary sinus have generally been unsuccessful and, moreover, have re-
EXPERIENCE in more than 150 patients with supraventricular tachycardia refractory to pharmacologic treatment has indicated that catheter ablation of the atrioventricular junction results in good or excellent arrhythmia control in approximately 90% of patients. 1,2 Catheter ablation of accessory pathways has also been attempted, but with less overall success. Attempts at ablation of left-sided accessory pathways by shocks delivered within the coronary sinus have generally been unsuccessful and, moreover, have re-sulted in perforation of the coronary sinus.3 Catheter ablation of right-sided accessory pathways has been limited by difficulty in precisely localizing these pathways.46 Attempts at transcatheter ablation of posteroseptal accessory pathways have met with some degree of success but, to date, the total published experience with this technique has consisted of only six patients.7-10 The posteroseptal accessory pathway was successfully ablated in four of these six patients, and no complications were reported. However, only two cases in which the procedure was successful were reported in detail.7 10 Although encouraging, the results reported to date are clearly too preliminary to allow valid conclusions regarding the efficacy or safety of the catheter ablation technique in the treatment of patients who have a posteroseptal accessory pathway.
The purpose of this report is to present the results of CIRCULATION THERAPY AND PREVENTION-ARRHYTHMIA attempted catheter ablation of a posteroseptal accessory pathway in a series of eight patients to help define the efficacy and safety of this new alternative to surgical ablation of posteroseptal accessory pathways.
Methods
Patient characteristics. The subjects of this report were five men and three women who had recurrent, symptomatic orthodromic reciprocating tachycardia. Their mean age was 31 + 10 years (mean + SD). Seven patients had the Wolff-ParkinsonWhite syndrome and a documented history of between one and six episodes of atrial fibrillation at an average rate varying between 220 and 300 beats/min. One patient (No. 4) had a concealed bypass tract and no history of atrial fibrillation. Seven patients had been treated with a mean of 2.3 + 1.4 antiarrhythmic drugs that were either ineffective or not tolerated because of side effects. One patient did not undergo a clinical trial of antiarrhyhmic drug treatment before the attempt at catheter ablation. Patient 1 was the subject of a prior report.7
Baseline electrophysiologic study. Before catheter ablation, each patient underwent an electrophysiologic study while in the fasting, unsedated state, at least four half-lives after discontinuation of antiarrhythmic drugs. Quadripolar electrode catheters were introduced through a femoral or subclavian vein and positioned within the right atrium, right 'ventricle, coronary sinus, and across the tricuspid valve for recording the His bundle electrogram. The baseline accessory pathway conduction properties and refractory periods are listed in table 1. When determination of the anterograde or retrograde effective refractory period of the accessory pathway was limited by atrial or ventricular refractoriness, the accessory pathway effective refractory period was considered to be equal to or less than the atrial functional refractory period or the ventricular effective refractory period.
Orthodromic reciprocating tachycardia was induced in each CVentriculoatrial interval recorded at the os of the coronary sinus during orthodromic reciprocating tachycardia.
patient. Participation of an accessory pathway as the retrograde limb of the tachycardia circuit was proven with use of standard criteria. l 1 Mapping of the accessory pathway was performed by recording atrial electrograms during orthodromic reciprocating tachycardia at various locations in the coronary sinus and around the tricuspid anulus. A posteroseptal accessory pathway was thought to be present if the earliest atrial activation during orthodromic reciprocating tachycardia was recorded at the os of the coronary sinus. Six patients were found to have a single posteroseptal accessory pathway, whereas two patients (Nos. 7 and 8) had both a posteroseptal and a right anterior accessory pathway. The interval between the onset of ventricular activation and the atrial electrogram recorded at the os of the coronary sinus during orthodromic reciprocating tachycardia varied from 77 to 130 msec (table 1) .
In five patients, 1 to 1.5 g of intravenous procainamide (mean serum level 8.2 + 3.1 mg/ml) was administered and found not to have any appreciable effects on accessory pathway conduction or refractoriness. Electropharmacologic testing was not performed in patient 3 or 4.
Catheter ablation protocol. The patients were offered the options of treatment with an investigational or, if appropriate, a conventional antiarrhythmic drug, surgical accessory pathway ablation, or catheter ablation. The two patients who had dual accessory pathways chose to undergo an attempt at catheter ablation of the posteroseptal accessory pathway in hopes of improving symptoms or as a prelude to surgical ablation of the right anterior accessory pathway. Before undergoing the catheter ablation procedure, each patient provided informed consent under a protocol approved by the Committee on Human Research at the University of California, San Francisco, or the University of Michigan.
Patients were brought to the electrophysiology laboratory while they were in the fasting, unsedated state. Blood pressure was monitored with a No. 5F cannula inserted into a femoral artery. An electrode catheter was inserted into a femoral vein and positioned against the right ventricular apex for pacing, if needed.
A No. 6F or 7F central lumen catheter was inserted into a subclavian vein and positioned in the coronary sinus under fluoroscopic guidance. After injection of contrast material to visualize the location of the os of the coronary sinus, this catheter was removed and replaced with a No. 6F or 7F quadripolar electrode catheter with 1 cm interelectrode distance (USCI, Billerica, MA). This catheter was positioned in the coronary sinus such that the proximal pair of electrodes straddled the os (figure 1). This proximal pair of electrodes was made electrically common and connected to the cathodal output of a defibrillator (PhysioControl, Redmond, WA). A 16 cm patch electrode (R-2 Corp., Skokie, IL) was placed over the midthoracic spine and connected to the anodal sink of the defibrillator. The patients were then anesthetized with sodium thiopental or sodium methohexital, and two or three 200 to 400 J discharges synchronized to the QRS were delivered within a 30 min period.
Atrial and ventricular stimulation were performed 5 to 10 min after each shock to assess their short-term effects on the accessory pathway.
After the ablation procedure, serial creatine kinase and creaitine kinase-MB fraction levels were measured and the patients patients who had an isolated posteroseptal accessory pathway. In patient 8, the effect of the intracardiac shocks on the posteroseptal accessory pathway was assessed by direct epicardial mapping 11 months later, at the time of surgical ablation of the right anterior accessory pathway. Patient 7 has not undergone followup electrophysiologic testing.
In three patients (Nos. 1, 5, and 6) coronary angiography was performed and the coronary sinus was visualized during the venous phase 4 months after the catheter ablation procedure. In patient 8, the coronary sinus was inspected directly at the time of surgical ablation of a right-sided accessory pathway 11 months after the catheter ablation procedure.
Results
Immediate results (table 2) . The initial shock was either 300 or 400 J in strength. The immediate effect of this initial shock was to abolish anterograde conduction through the posteroseptal accessory pathway in four of the seven patients in whom the bypass tract was not concealed. In patient 6, anterograde conduction was not abolished after an initial shock of 300 J, but was abolished after a second shock of 400 J. In the two patients with dual accessory pathways (patients 7 Incremental ventricular pacing demonstrated that ventriculoatrial dissociation was present in two patients (Nos. 2 and 4). One-to-one retrograde conduction through the atrioventricular node was present to a minumum paced cycle length of between 350 and 700 msec (mean 467 ± 202 msec) in four patients. The retrograde effective refractory period could be determined in four patients and varied between 220 and 340 msec (mean 273 ± 61). In patient 3, the presence of retrograde accessory pathway conduction prevented the measurement of retrograde conduction or refractoriness in the atrioventricular junction.
Other effects of the transcatheter shocks. The mean peak creatine kinase serum level after delivery of the shocks was 364 ± 360 IU/liter, and the mean peak MB fraction was 31 + 28 IU/liter. A technetium pyrophosphate scintigram showed no myocardial uptake in four patients and focal lateral ventricular uptake suggestive of a myocardial infarction in one patient.
Occasional multiform ventricular premature depolarizations were noted in patient 3 during the first 4 days after the catheter ablation procedure. Ventricular or supraventricular tachycardia was not observed in, any patient.
In three patients (Nos. 1, 5, and 6) coronary angiography demonstrated a normal left and right coronary artery and a normal coronary sinus. In patient 8, the coronary sinus and right atrium appeared grossly normal on direct visual inspection at the time of surgical ablation of a right-sided accessory pathway 11 months after delivery of the transcatheter shocks.
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Discussion
The results presented herein suggest that the delivery of transcatheter shocks at the os of the coronary sinus is an effective and safe technique by which posteroseptal accessory pathways can be ablated on a long-term basis. Evaluation at 4 or more months of follow-up demonstrated that accessory pathway conduction was completely eliminated, or at least modified so that potentially life-threatening tachyarrhythmias no longer occurred, in a minimum of six of eight patients (75%). Because the ablation procedure may have been effective in patient 7 The close proximity of posteroseptal accessory pathways to the os of the coronary sinus provides the anatomic basis for the effectiveness of the technique used in the present report, in which transcatheter shocks are applied at the coronary sinus os. Although the reason that the ablation procedure was not successful in patient 3 is unclear, it may be that the posteroseptal accessory pathways do not always originate at the rim of the coronary sinus os.
A prior study on the effects of transcatheter shocks delivered within the coronary sinus in patients with left-sided accessory pathways demonstrated that perforation of the coronary sinus and cardiac tamponade was possible with two shocks of 100 and 150 J. 3 Although the shocks used in the present report were as high as 400 J in strength, no patient developed signs of coronary sinus perforation or cardiac tamponade. However, great care was taken to deliver these highenergy shocks at the os, where there is atrial myocardium, instead of within the coronary sinus, which is a thin-walled vein. THERAPY AND PREVENTION-ARRHYTHMIA been delivered. Although this suggested that there was persisting anterograde conduction over the posteroseptal accessory pathway, direct epicardial mapping at the time of surgical ablation of the right-sided accessory pathway in patient 8 demonstrated no evidence of anterograde or retrograde conduction through a posteroseptal accessory pathway. The reason that the delta wave pattern did not change despite complete conduction block in the posteroseptal accessory pathway is unclear.
As would be expected, transcatheter shocks of 200 to 400 J resulted in some degree of myocardial injury, as evidenced by release of creatine-kinase MB fraction. However, technetium pyrophosphate scintigrams demonstrated either no myocardial uptake or a small area of focal uptake, suggesting that the injury was very localized. Although ventricular premature depolarizations occurred transiently in one patient, no patient experienced a malignant ventricular arrhythmia as a complication of the transcatheter shocks.
Coronary angiography in three patients demonstrated that the transcatheter shocks did not cause any damage to the coronary arteries. Whereas shocks within the coronary sinus frequently result in coronary sinus obstruction or stenosis,3' 17 no coronary sinus abnormalities were observed as a result of transcatheter shocks to the coronary sinus os in the four patients in the present series in whom the coronary sinus was visualized either directly or during angiography.
Approximately one-third of accessory atrioventricular connections are posteroseptal in location.'3 In the past, if the patient with a posteroseptal pathway was an appropriate candidate for nonpharmacologic therapy, the definitive form of treatment was surgical ablation of the accessory pathway. However, even in the best of hands, surgical ablation of posteroseptal accessory pathways is more difficult than ablation of free-wall accessory pathways, and is associated with approximately a 10% risk of complete atrioventricular block. 13 Our results suggest that catheter ablation of posteroseptal accessory pathways may be a viable alternative to surgical ablation. Although confirmation in a larger number of patients is needed, the long-term success rate of the catheter ablation technique described herein appears to be at least 75% and the morbidity rate appears to be acceptably small.
